Roche launches first in vitro diagnostic IHC test to detect ROS1 protein in cancers
The VENTANA ROS1 (SP384) rabbit monoclonal primary antibody is designed to effectively identify elevated ROS1 protein expression
The VENTANA ROS1 (SP384) rabbit monoclonal primary antibody is designed to effectively identify elevated ROS1 protein expression
Abbott's AlinIQ Integrated Platform analyzes currently siloed datasets to help hospitals make more informed decisions based on their unique needs
Zymo Research receives a record-breaking four trophies in the latest awards recognizing the laboratory products scientists love the most
Agreement will address limitations in development of multiplex point-of-care Lateral Flow Assay diagnostic tests
Cresset and Elixir to preview Torx™ at key European events for medicinal chemists
We celebrate the clinical laboratory products that have made the most difference to your lab work or point-of-care testing and reveal our most popular clinical content of the year
Thermo Scientific MD portfolio provides an extensive range of chromatography and mass spectrometry instruments for laboratory developed tests
Thermo Fisher Scientific is exhibiting in booth #2110 at the Anaheim Convention Center, Anaheim, California, August 4–8
Company will showcase its new and next-generation products, including Ortho’s VITROS® XT 7600 Integrated System
New Rubella VLPs promise a reliable source of reagents for consistency in immunoassay development and manufacturing
Download the microbiome workflow poster from Eppendorf
The new system demonstrates bioMérieux’s commitment to automated blood culture - a foundational step to infectious disease diagnosis
AKO MED to exclusively distribute Unyvero A50 portfolio in Serbia, North Macedonia, Bosnia Hercegovina, and Montenegro
Discover the latest technology for the identification of structural variants (SVs) within the human genome
Combination of Tecentriq and chemotherapy has demonstrated a significant overall survival (OS) and progression-free survival (PFS) benefit
Akoya Biosciences determines that multiplex immunofluorescence technology preserves critical data missed by other biomarker strategies
Landmark 15-year study funded by the MS Society has potential to predict the progression of the condition